Related Experiment Video
Updated: Jun 22, 2026

A Catheter-Related Candida albicans Infection Model in Mouse
Published on: March 22, 2024
[Candidemia in an intensive care unit]
Dalia Adukauskiene1, Aida Kinderyte, Asta Dambrauskiene
1Department of Intensive Care, Kaunas University of Medicine, Kaunas, Lithuania. daliaadu@gmail.com
Abstract:
Candidemia is becoming more actual because of better survival of even critically ill patients, wide use of antimicrobials, and increased numbers of invasive procedures and manipulations. Diagnosis of candidemia remains complicated, and costs of treatment and mortality rates are increasing. OBJECTIVE. To evaluate the pathogens of candidemia, risk factors and their influence on outcome. MATERIAL AND METHODS. Data of 41 patients with positive blood culture for Candida spp., who were treated in the intensive care units at the Hospital of Kaunas University of Medicine, were analyzed retrospectively. RESULTS. Candidemia was caused by Candida albicans (C. albicans) in 48.8% (n=20) of patients and by non-albicans Candida in 51.2% (n=21) of patients. The main cause of candidemia was C. albicans in 2004 (83.3%, n=5), but in 2005 (63.6%, n=7), in 2006 (57.1%, n=4), and in 2007 (52.9%, n=9), the main cause was non-albicans Candida spp. The number of candidemia cases caused by C. albicans was decreased in 2005, 2006, and 2007 as compared with 2004, and the number of candidemia caused by non-albicans Candida spp. was decreased, respectively (P<0.05). More than 65% (n=34) of patients had severe disease (P<0.05). Lethal outcome was recorded in 58.5% of patients with candidemia. Mechanical ventilation was used in 76.9% (n=20) and urinary bladder catheter in 72.1% (n=19) of non-survivors and in 23.1% (n=6) and 26.9% (n=7) of survivors, respectively (P<0.05). CONCLUSIONS. There is an increase in the prevalence of candidemia in the intensive care units during the 4-year period; half of candidemia cases were caused by non-albicans Candida spp., and patients with candidemia caused by non-albicans Candida spp. are at higher risk of mortality. Therefore, for the empirical treatment of septic conditions in an intensive care unit, when invasive fungal infection is suspected, we recommend using an antifungal agent of non-azole class until a pathogen of candidemia is determined. Severe disease is evaluated as a risk factor for candidemia. Patients with oncological diseases are at significantly higher risk for candidemia caused by non-albicans Candida spp. Use of mechanical ventilation and urinary bladder catheter is a risk factor for lethal outcome.
Insights
Candidemia cases are rising, with non-albicans Candida species increasingly causing infections and leading to higher mortality. Early empirical treatment with non-azole antifungals is recommended for suspected invasive fungal infections in intensive care units.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Mycology
Background:
- Candidemia is an increasing concern due to improved survival of critically ill patients, widespread antimicrobial use, and more invasive procedures.
- Diagnosis of candidemia is challenging, contributing to rising treatment costs and mortality rates.
Purpose of the Study:
- To evaluate the pathogens causing candidemia, identify risk factors, and assess their impact on patient outcomes.
- To analyze trends in candidemia pathogens over a four-year period in intensive care units.
Main Methods:
- Retrospective analysis of data from 41 patients with positive blood cultures for Candida species in intensive care units.
- Evaluation of patient demographics, clinical conditions, treatments, and outcomes.
Main Results:
- Candida albicans caused 48.8% of candidemia cases, while non-albicans Candida species accounted for 51.2%.
- The proportion of non-albicans Candida species as the primary cause of candidemia increased from 2004 to 2007 (from 16.7% to 47.1%).
- Mortality was high at 58.5%, with mechanical ventilation and urinary bladder catheter use being significant risk factors for lethal outcomes.
Conclusions:
- There is a notable increase in candidemia prevalence in intensive care units.
- Non-albicans Candida species are becoming more prevalent and are associated with a higher risk of mortality.
- Empirical treatment with non-azole antifungal agents is recommended for suspected invasive fungal infections in intensive care units when the specific pathogen is undetermined.
More Related Videos
Related Concept Videos
Candidiasis
Cryptococcal Meningitis
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction

